MA26897A1 - TYPE I SODIUM-HYDROGEN EXCHANGER INHIBITOR (NHE-1) - Google Patents

TYPE I SODIUM-HYDROGEN EXCHANGER INHIBITOR (NHE-1)

Info

Publication number
MA26897A1
MA26897A1 MA26875A MA26875A MA26897A1 MA 26897 A1 MA26897 A1 MA 26897A1 MA 26875 A MA26875 A MA 26875A MA 26875 A MA26875 A MA 26875A MA 26897 A1 MA26897 A1 MA 26897A1
Authority
MA
Morocco
Prior art keywords
nhe
sodium
type
hydrogen exchanger
exchanger inhibitor
Prior art date
Application number
MA26875A
Other languages
French (fr)
Inventor
George Chen Weichao
David Cox Eric
Guzman-Perez Angel
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA26897A1 publication Critical patent/MA26897A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA26875A 2000-04-28 2002-10-18 TYPE I SODIUM-HYDROGEN EXCHANGER INHIBITOR (NHE-1) MA26897A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
MA26897A1 true MA26897A1 (en) 2004-12-20

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26875A MA26897A1 (en) 2000-04-28 2002-10-18 TYPE I SODIUM-HYDROGEN EXCHANGER INHIBITOR (NHE-1)

Country Status (40)

Country Link
EP (1) EP1276737A1 (en)
JP (1) JP2003531900A (en)
KR (1) KR20020093079A (en)
CN (1) CN1225466C (en)
AP (1) AP2002002651A0 (en)
AR (1) AR028375A1 (en)
AU (1) AU2001235896A1 (en)
BG (1) BG107139A (en)
BR (1) BR0110268A (en)
CA (1) CA2407535A1 (en)
CO (1) CO5221125A1 (en)
CR (1) CR6797A (en)
CZ (1) CZ20023408A3 (en)
DZ (1) DZ3310A1 (en)
EA (1) EA004882B1 (en)
EE (1) EE200200615A (en)
GT (1) GT200100064A (en)
HN (1) HN2001000042A (en)
HR (1) HRP20020851A2 (en)
HU (1) HUP0300651A2 (en)
IL (1) IL152075A0 (en)
IS (2) IS6567A (en)
MA (1) MA26897A1 (en)
MX (1) MXPA02010600A (en)
MY (1) MY133842A (en)
NO (1) NO20025132L (en)
NZ (1) NZ521348A (en)
OA (1) OA12256A (en)
PA (1) PA8513301A1 (en)
PE (1) PE20011270A1 (en)
PL (1) PL357765A1 (en)
SK (1) SK14872002A3 (en)
SV (1) SV2002000418A (en)
TN (1) TNSN01065A1 (en)
TR (1) TR200202439T2 (en)
UA (1) UA73348C2 (en)
UY (1) UY26680A1 (en)
WO (1) WO2001083470A1 (en)
YU (1) YU79602A (en)
ZA (1) ZA200208605B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03006872A (en) * 2001-01-31 2003-11-13 Pfizer Prod Inc Ethanolates of sodium-hydrogen exchanger type-1 inhibitor.
CA2469305A1 (en) * 2001-12-19 2003-06-26 Frank Robert Busch Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
EP1499317A1 (en) * 2002-05-02 2005-01-26 Pfizer Products Inc. Treatment of diabetes and diabetic complications with nhe-1 inhibitors
FR2840302B1 (en) * 2002-06-03 2004-07-16 Aventis Pharma Sa ISOINDOLONE DERIVATIVES, PREPARATION METHOD AND INTERMEDIARY THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
ES2220185B1 (en) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas NEW INHIBITOR PEPTIDE OF THE NA + / H + EXCHANGER (PINHE), AND ITS APPLICATIONS.
US7550480B2 (en) * 2003-02-14 2009-06-23 Smithkline Beecham Corporation Compounds
RU2518741C1 (en) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" MEDICATION, INHIBITING Na+/H+-EXCHANGE, AND HALOGENIDES OF 1-DIALKYLAMINOETHYL-3-[SUBSTITUTED(DISUBSTITUTED)PHENACYL]-2-AMINOBENZIMIDAZOLIUM

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1056729B1 (en) * 1998-02-27 2004-12-29 Pfizer Products Inc. N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia

Also Published As

Publication number Publication date
EA200201023A1 (en) 2003-02-27
YU79602A (en) 2006-05-25
ZA200208605B (en) 2003-10-24
OA12256A (en) 2003-11-06
AU2001235896A1 (en) 2001-11-12
UA73348C2 (en) 2005-07-15
GT200100064A (en) 2002-03-22
IL152075A0 (en) 2003-05-29
HRP20020851A2 (en) 2005-02-28
CR6797A (en) 2004-05-17
EP1276737A1 (en) 2003-01-22
TR200202439T2 (en) 2003-02-21
SK14872002A3 (en) 2004-03-02
UY26680A1 (en) 2001-12-28
CN1225466C (en) 2005-11-02
PA8513301A1 (en) 2003-09-05
NZ521348A (en) 2004-09-24
EE200200615A (en) 2004-04-15
HN2001000042A (en) 2001-07-09
BG107139A (en) 2003-07-31
DZ3310A1 (en) 2001-11-07
WO2001083470A1 (en) 2001-11-08
CZ20023408A3 (en) 2004-01-14
CA2407535A1 (en) 2001-11-08
CO5221125A1 (en) 2002-11-28
EA004882B1 (en) 2004-08-26
NO20025132L (en) 2002-12-12
AP2002002651A0 (en) 2002-12-31
AR028375A1 (en) 2003-05-07
IS6588A (en) 2002-10-21
MY133842A (en) 2007-11-30
JP2003531900A (en) 2003-10-28
BR0110268A (en) 2003-12-30
MXPA02010600A (en) 2003-03-10
PE20011270A1 (en) 2001-12-12
HUP0300651A2 (en) 2003-07-28
KR20020093079A (en) 2002-12-12
IS6567A (en) 2002-09-24
SV2002000418A (en) 2002-07-03
TNSN01065A1 (en) 2005-11-10
CN1426404A (en) 2003-06-25
PL357765A1 (en) 2004-07-26
NO20025132D0 (en) 2002-10-25

Similar Documents

Publication Publication Date Title
DE60101714D1 (en) heat exchangers
DE60012822D1 (en) heat exchangers
DE69911131D1 (en) heat exchangers
DE60138964D1 (en) Heat Exchanger
DE60138767D1 (en) Heat Exchanger
DE60116596T8 (en) Heat Exchanger
DE10083636T1 (en) heat exchangers
DE69910301D1 (en) Heat exchanger coil
DE60115565D1 (en) heat exchangers
DE60023394D1 (en) heat exchangers
DE60027489D1 (en) heat exchangers
ITMI20002039A0 (en) HEAT EXCHANGER
MA26897A1 (en) TYPE I SODIUM-HYDROGEN EXCHANGER INHIBITOR (NHE-1)
FI20002454A0 (en) Heat exchanger
DE69824454D1 (en) Heat Exchanger
DE60006813D1 (en) heat exchangers
ITMI20001583A0 (en) HEAT EXCHANGER
DE59905017D1 (en) Heat exchanger
NO20021821D0 (en) Sodium-hydrogen exchange type 1 inhibitor crystals
DE50114466D1 (en) Cross-flow radiator
DE60102847D1 (en) heat exchangers
FI20002648A (en) Heat exchanger
FI981909A (en) heat exchanger
ATA200698A (en) HEAT EXCHANGER
ATA58798A (en) HEAT EXCHANGER BLOCK